fda compounding semaglutide warning letters news US warns online vendors to stop selling unapproved weight-loss drugs FDA warnings against compounded GLP-1s

JAMA Ophthalmology found a potential link between Now, a new investigatory review just published in According to Bradley Katz, MD, PhD, an ophthalmologist at the John A

The metabolic activation from glucagon receptor stimulation may increase evening alertness in some individuals

Research goes back to the early 1990s, with 30-plus years of safety data

Understanding why this occurs and how to manage it can help you stay consistent with your weight loss journey

Oral semaglutide has become an option for people who prefer pills instead of injections

In Phase 3 clinical trials, retatrutide is usually increased every four weeks